We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VEND:EURONEXT OSLOVend Marketplaces ASA Analysis

Data as of 2026-08-17 - not real-time

NOK 247.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

VEND MARKETPLACES ASA is priced at NOK 247.60 and its moving averages line up in bearish order, the shorter trailing the longer. Momentum indicators put RSI at 54.1 (neutral) with MACD reading bullish. The recent range runs from support at NOK 221.20 up to resistance at NOK 254.80.
Multiples put this in fair territory: 24.0 times earnings against the sector's 16.4. Sell-side targets cluster 18.7% above the current quote. The 1.00% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 34.0%, a beta of 0.34 and a maximum drawdown of 41.3%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 4 out of 10.

Top Market Events

Yahoo Finance4dVEND MARKETPLACES ASA VEND.Yahoo Finance3monVEND MARKETPLACES ASA SBSNY Q1 FY2026 earnings call transcriptEarnings call Vend delivered Q1 2026...Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 260.12
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 24.0 versus sector average of 16.4
  • Trading below the 200-day average of 260.12

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • P/E of 24.0 versus sector average of 16.4
  • Negative profit margin of -117.7%
  • Analyst targets imply +18.7% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin-117.72%
P/E Ratio24.0
ROE-37.70%
ROA3.86%
Debt/Equity16.90
P/B Ratio3.2
Op. Cash FlowNOK2.2B
Free Cash FlowNOK2.2B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI54.1
SupportNOK 221.20
ResistanceNOK 254.80
MA 20NOK 241.33
MA 50NOK 242.35
MA 200NOK 260.12
MACDBullish
VolumeDecreasing
Fear & Greed Index94.71

Valuation

Fair ValueNOK 151.03
Target PriceNOK 293.80
Upside/Downside18.66%
GradeFair
TypeBlend
Dividend Yield1.00%

Risk Assessment

Beta0.34
Volatility34.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.